mStab1-1.26, InVivoPure
mStab1-1.26, InVivoPure - Image 2

mStab1-1.26, InVivoPure

ID: AK726P Category:

mStab1-1.26, InVivoPure is a mouse monoclonal antibody against mouse Stabilin-1 (UniProt
entry: Q8R4Y4), also known as Clever-1 or FEEL-1.

The antibody is produced exclusively under serum-free conditions from hybridoma and purified
through one-step purification with Protein-G affinity chromatography.

In stock

Delivery time: 2-5 days

From: 1.073,60 € Excl. VAT and delivery costs

Please contact us for larger quantities.

Endotoxin level ≤ 2 EU/mg

mStab1-1.26, InVivoPure is a mouse monoclonal antibody against mouse Stabilin-1 (UniProt
entry: Q8R4Y4), also known as Clever-1 or FEEL-1. Stabilin-1 is a scavenger receptor expressed
by sinusoidal endothelial cells (ECs) in the liver, lymph nodes, spleen, and bone marrow [1].
Stabilin-1 is expressed in human breast cancer and supports tumor growth [2]. It is found on
subset of macrophages that mediate tissue homeostasis and is involved in liver fibrosis [3].
mStab1-1.26 or mStabilin-1 (clone 1.26) is first mentioned by Schledzewski et al. (2006) [4]. To
generate the antibody, a recombinant mouse stabilin-1 fragment (residues 1–710 of Q8R4Y4)
fused to mouse IgG2b-Fc was purified from stably-transfected HEK293 cells and used to
immunize stabilin-1 knockout mice. mStab1-1.26 recognizes stabilin-1 in rat and mouse.

The antibody is produced exclusively under serum-free conditions from hybridoma and purified
through one-step purification with Protein-G affinity chromatography.

 

Product-ID: AK726P
Immunogen: Recombinant mouse Stabilin-1 fragment from HEK 293 (residues 1–710 of Q8R4Y4, fused to mouse-IgG2b-Fc)
Host: Mouse
Clonality: Monoclonal
Isotype: Mouse IgG1κ
Formulation: Liquid, PBS, pH 7.4, 0.2 μm sterile filtered
Concentration: ≥ 1.00 mg/ mL
Purity: ≥ 90% (CGE, reducing conditions)
Endotoxin: ≤ 2 EU/ mg (LAL test)
Recommended Isotype Control: Mouse IgG1- Antibody (AK3421)

 

The product is for research use or for further manufacturing only and not for use in diagnostic or therapeutic procedures.

Additional information

Literature

[1] O. Politz et al., “Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues,”
Biochem. J., vol. 362, no. 1, pp. 155–164, 2002, doi: 10.1042/0264-6021:3620155.
[2] V. Riabov et al., “Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary
adenocarcinoma mouse model,” Oncotarget, vol. 7, no. 21, pp. 31097–31110, 2016, doi:
10.18632/oncotarget.8857.
[3] P. Rantakari et al., “Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis
and prevent fibrosis in chronic liver injury,” Proc. Natl. Acad. Sci. U. S. A., vol. 113, no. 33, pp. 9298–9303, 2016,
doi: 10.1073/pnas.1604780113.
[4] K. Schledzewski et al., “Lympathic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-
1+, F4/80+, CD11b+ macropahages in malignant tumours and wound healing tissue in vivo and in bone
marrow cultures in vitro: Implications for the assessment of lymphangiogenesis,” J. Pathol., vol. 209, no. 1, pp.
67–77, 2006, doi: 10.1002/path.1942.
Product citations

1.
Manta CP, Leibing T, Friedrich M, Nolte H, Adrian M, Schledzewski K, et al. Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression. Circulation. 2022;146(23):1783–99.
2.
Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, et al. Enhanced antibody production in clever-1/Stabilin-1-deficient mice. Front Immunol. 2018;9(OCT):1–11.
3.
Karikoski M, Marttila-Ichihara F, Elima K, Rantakari P, Hollmén M, Kelkka T, et al. Clever-1/stabilin-1 controls cancer growth and metastasis. Clin Cancer Res. 2014;20(24):6452–64.
4.
Karikoski M, Irjala H, Maksimow M, Miiluniemi M, Granfors K, Hernesniemi S, et al. Clever‐1/Stabilin‐1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation. Eur J Immunol [Internet]. 2009 Dec;39(12):3477–87.
5.
Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, Ganss R, et al. Lympathic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macropahages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: Implications for the assessment of lymphangiogenesis. J Pathol. 2006;209(1):67–77.
Document

Product Information Sheet – AK726P
Notice

The product is for research use or for further manufacturing only and not for use in diagnostic or therapeutic procedures.

Reviews

There are no reviews yet.

Be the first to review “mStab1-1.26, InVivoPure”